vTv Therapeutics (VTVT) Payables (2016 - 2025)
Historic Payables for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $10.1 million.
- vTv Therapeutics' Payables rose 6272.08% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 6272.08%. This contributed to the annual value of $5.0 million for FY2024, which is 5181.64% down from last year.
- Per vTv Therapeutics' latest filing, its Payables stood at $10.1 million for Q3 2025, which was up 6272.08% from $5.2 million recorded in Q2 2025.
- vTv Therapeutics' 5-year Payables high stood at $12.5 million for Q1 2022, and its period low was $4.2 million during Q1 2025.
- Its 5-year average for Payables is $7.6 million, with a median of $7.5 million in 2022.
- Per our database at Business Quant, vTv Therapeutics' Payables tumbled by 5793.44% in 2021 and then surged by 15123.87% in 2022.
- Quarter analysis of 5 years shows vTv Therapeutics' Payables stood at $8.3 million in 2021, then fell by 8.96% to $7.5 million in 2022, then soared by 38.42% to $10.4 million in 2023, then crashed by 51.82% to $5.0 million in 2024, then surged by 101.53% to $10.1 million in 2025.
- Its Payables stands at $10.1 million for Q3 2025, versus $5.2 million for Q2 2025 and $4.2 million for Q1 2025.